Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus

Affiliations

¹ Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan yasutonko@a8.keio.jp.
² Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
³ Division of Haematology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
⁴ Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
⁵ Department of Infectious Diseases, Center for Infection Diseases and Infection Control, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.

Comment

Yasushi Kondo et al. Ann Rheum Dis. 2021 May.

. 2021 May;80(5):e77.

doi: 10.1136/annrheumdis-2020-218157. Epub 2020 Aug 5.

¹ Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan yasutonko@a8.keio.jp.
² Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
³ Division of Haematology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
⁴ Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
⁵ Department of Infectious Diseases, Center for Infection Diseases and Infection Control, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.

No abstract available

Keywords: antiphospholipid syndrome; immune system diseases; lupus erythematosus, systemic.

Conflict of interest statement

Competing interests: None declared.

Response to: 'Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus' by Kondo et al.
Mathian A, Amoura Z. Mathian A, et al. Ann Rheum Dis. 2021 May;80(5):e78. doi: 10.1136/annrheumdis-2020-218176. Epub 2020 Aug 5. Ann Rheum Dis. 2021. PMID: 32759253 No abstract available.

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.
Mathian A, Mahevas M, Rohmer J, Roumier M, Cohen-Aubart F, Amador-Borrero B, Barrelet A, Chauvet C, Chazal T, Delahousse M, Devaux M, Euvrard R, Fadlallah J, Florens N, Haroche J, Hié M, Juillard L, Lhote R, Maillet T, Richard-Colmant G, Palluy JB, Pha M, Perard L, Remy P, Rivière E, Sène D, Sève P, Morélot-Panzini C, Viallard JF, Virot JS, Benameur N, Zahr N, Yssel H, Godeau B, Amoura Z. Mathian A, et al. Ann Rheum Dis. 2020 Jun;79(6):837-839. doi: 10.1136/annrheumdis-2020-217566. Epub 2020 Apr 24. Ann Rheum Dis. 2020. PMID: 32332072 No abstract available.